President Donald Trump declared a “shock to the system” as he unveiled historic prescription drug price cuts that promise to reshape healthcare across the nation. Partnering with Pfizer, Trump announced that Medicaid programs will now access medications at the same low prices offered to the world’s richest nations — a move that slashes costs for millions of Americans. Drugs like Eucrisa, Xeljanz, and Zavzpret will drop by up to 80 percent, marking one of the boldest consumer victories in U.S. medical history.
Continues…
